@article{78cb21e787b24ba5b650e3c926b926a4,
title = "A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma",
author = "Alessandra Tedeschi and Richard Greil and Fatih Demirkan and Tadeusz Robak and Carol Moreno and Barr, {Paul M.} and Bertrand Anz and David Simpson and Gianluca Gaidano and Osnat Bairey and Don Stevens and Devinder Gill and Flinn, {Ian W.} and Kipps, {Thomas J.} and Burger, {Jan A.} and Jennifer Lin and Thomas Webb and Viktor Fedorov and Lori Styles and Gribben, {John G.}",
note = "Funding Information: Funding: this study was sponsored by Pharmacyclics LLC, an AbbVie Company. Editorial support was provided by Emily Chastain, PhD, an employee of Pharmacyclics LLC, an AbbVie Company. Correspondence: ALESSANDRA TEDESCHI. alessandra.tedeschi@ospedaleniguarda.it doi:10.3324/haematol.2019.223743 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.",
year = "2020",
doi = "10.3324/haematol.2019.223743",
language = "English (US)",
volume = "105",
pages = "E164--E168",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "4",
}